Moderna Inc. Watch

EX-10.1

from 10-Q 6 pages Moderna, Inc. 2018 Employee Stock Purchase Plan

12/34/56

EX-10.23

from 10-K 7 pages Non-Qualified Stock Option Agreement for Company Employees Under the Moderna, Inc. 2018 Stock Option and Incentive Plan

12/34/56

EX-10.22

from 10-K 4 pages Restricted Stock Unit Award Agreement for Company Employees Under the Moderna, Inc. 2018 Stock Option and Incentive Plan

12/34/56

EX-10.21

from 10-K 7 pages Moderna, Inc. 2018 Employee Stock Purchase Plan

12/34/56

EX-10.15

from 10-K 16 pages Personal and Confidential December 8, 2023 (As Revised on December 30, 2023) via Electronic Mail [***] Arpa Garay [***] [***] Re: Executive Separation and Transitional Services Agreement

12/34/56

EX-10.16

from 10-K 5 pages April 21, 2022 via Electronic Mail

12/34/56

EX-10.11

from 10-K 11 pages Moderna, Inc. Amended and Restated Executive Severance Plan

12/34/56

EX-10.3

from 10-Q 18 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***].” Such Identified Information Has Been Excluded From This Exhibit Because It (I) Is Not Material and (II) Is the Type of Information That the Registrant Treats as Private and Confidential

12/34/56

EX-10.2

from 10-Q 5 pages August 15, 2022 via Electronic Mail ([***]) James Mock [***] [***]

12/34/56

EX-10.1

from 10-Q 3 pages Moderna, Inc. Amended and Restated Non-Employee Director Compensation Policy

12/34/56

EX-10.6

from 10-Q 14 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***].” Such Identified Information Has Been Excluded From This Exhibit Because It (I) Is Not Material and (II) Is the Type of Information That the Registrant Treats as Private and Confidential

12/34/56

EX-10.4

from 10-Q 5 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***].” Such Identified Information Has Been Excluded From This Exhibit Because It (I) Is Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential

12/34/56

EX-10.1

from 10-Q 3 pages Moderna, Inc. Amended and Restated Non-Employee Director Compensation Policy

12/34/56

EX-10.1

from 8-K/A 8 pages May 27, 2022 via Electronic Mail ([***]) Personal and Confidential David Meline [***] [***] Re: Updated Executive Retirement and Strategic Consulting Agreement Dear David: • the Company Shall Pay You for All Base Salary Plus Payment for Any Unused Vacation Accrued Through the Last Day of the Transition Period

12/34/56

EX-10.1

from 8-K/A 7 pages May 11, 2022 Personal and Confidential Jorge M. Gomez [***] [***], Nc 28207 Re: Executive Separation Agreement and Release to Be Signed and Returned No Later Than May 18, 2022

12/34/56

EX-10.5

from 10-Q 11 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***].” Such Identified Information Has Been Excluded From This Exhibit Because It (I) Is Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential

12/34/56

EX-10.4

from 10-Q 11 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***].” Such Identified Information Has Been Excluded From This Exhibit Because It (I) Is Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential

12/34/56

EX-10.2

from 10-Q 8 pages April 8, 2022 via Electronic Mail Personal and Confidential David Meline [***] [***] Re: Executive Retirement and Strategic Consulting Agreement Dear David

12/34/56

EX-10.1

from 10-Q 5 pages April 4, 2022 via Electronic Mail

12/34/56

EX-10.40

from 10-K 55 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***].” Such Identified Information Has Been Excluded From This Exhibit Because It (I) Is Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential

12/34/56